SHILPA MEDICARE
|
The Current P/E Ratio of SHILPA MEDICARE is 56.50.
| Share Price | ₹391.3 | Nov 13,2025 |
| Market Cap | ₹7,652.9 Cr | |
| Earnings-TTM | ₹135.5 Cr | TTM-Consolidated Results |
| Price/Earnings | 56.50x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of SHILPA MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹7,652.9 Cr] as on Nov 13,2025
(/) Earnings [ ₹135.5 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 56.50x ]
Thus, for SHILPA MEDICARE , the investors are currently willing to pay 56.50 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SHILPA MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SHILPA MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of SHILPA MEDICARE
PE Ratio Performance Analysis for SHILPA MEDICARE
- SHILPA MEDICARE 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 56.74x.
- SHILPA MEDICARE 's operated at median p/e ratio of 56.83x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SHILPA MEDICARE 's p/e ratio peaked in Mar2024 at 125.64x.
- SHILPA MEDICARE 's p/e ratio hit its five-year low in Mar2023 of 0x.
How does SHILPA MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| SHILPA MEDICARE | 135.45 | 56.50 | 7,652.9 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 10,517.90 | 39.60 | 416,477.0 |
| DIVIS LABORATORIES LTD | 2,485.00 | 70.40 | 174,934.0 |
| CIPLA LTD | 5,453.86 | 22.60 | 123,250.0 |
| TORRENT PHARMACEUTICALS LTD | 2,140.00 | 60.50 | 129,469.0 |
| DR REDDYS LABORATORIES LTD | 5,721.40 | 18.01 | 103,038.0 |
| MANKIND PHARMA LTD | 1,767.06 | 52.70 | 93,120.4 |
| ZYDUS LIFESCIENCES LTD | 4,973.40 | 19.10 | 95,008.6 |
| LUPIN LTD | 4,347.53 | 21.57 | 93,768.7 |
| AUROBINDO PHARMA LTD | 3,447.75 | 20.36 | 70,210.2 |
| ABBOTT INDIA LTD | 1,508.95 | 41.62 | 62,801.8 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SHILPA MEDICARE 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 18.01x |
| Max industry PE | 70.40x |
| Median industry PE | 39.60x |
| Average industry PE | 38.45x |
You may also like the below Video Courses